Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development, Validation, and Dissemination of an Integrated Risk Prediction Model and Decision Aid to Discern Aggressive vs Indolent Prostate Cancer (Aim 2A)

NCT02451345 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02451345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02451345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development, Validation, and Dissemination of an Integrated Risk Prediction Model and Decision Aid to Discern Aggressive vs Indolent Prostate Cancer (Aim 2A)
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Completed
Start date
March 25, 2015
Completion date
April 30, 2020
Enrollment
58 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer